SCHEMBL5873455

SCHEMBL5873455

NCCCC(=O)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL9233399 0.94 LMNA (0.50)
SCHEMBL13408163 0.91
SCHEMBL9101333 0.89 LMNA (0.46)
SCHEMBL9099521 0.89 LMNA (0.46)
SCHEMBL12653614 0.88 LMNA (0.59)
SCHEMBL5873441 0.88 LMNA (0.59)
SCHEMBL5873470 0.88 LMNA (0.59)
SCHEMBL5873474 0.88 LMNA (0.59)
SCHEMBL7446933 0.88 LMNA (0.59)
SCHEMBL3309097 0.88 LMNA (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6989052-B1 Phase change ink printing process XEROX CORPORATION (US) 2006-01-24 US claimed
US-20230106131-A1 POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF STAPLED PEPTIDES OHIO STATE INNOVATION FOUNDATION 2023-04-06 US disclosed
WO-2023018199-A1 NOVEL ANTIBIOTIC AND USE THEREOF 주식회사 레고켐바이오사이언스 2023-02-16 WO disclosed
US-20200276323-A1 POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF STAPLED PEPTIDES OHIO STATE INNOVATION FOUNDATION 2020-09-03 US disclosed